Cross-National Survey of Pharmaceutical Diversion
James A. Inciardi, Principal Investigator
Funding Source: Purdue Pharma
This project was designed to collect basic incidence data on the nature and extent of the diversion of numerous drugs with high potential for abuse, including alprazolam, buprenorphine, carisoprodol, diazepam, fentanyl, hydrocodone, hydromorphone, morphine, OxyContin, and other forms of oxycodone; and, in-depth data on diversion, patterns and mechanisms of diversion, and characteristics of diverters from the identified sentinel locations. The study targeted approximately 200 diversion investigators, from police departments and pharmaceutical boards in all 50 states, including rural, suburban, and urban areas. On a quarterly basis, the 200 investigators were sent a questionnaire which elicited the information noted above.
Inciardi, James A., Hilary L. Surratt, Theodore J. Cicero and Ronald A. Beard. “Prescription Opiod Abuse and Diversion in an Urban Community: The Results of an Ultra-Rapid Assessment. Pain Medicine. In Press.
Cicero, Theodore J., Hilary L. Surratt, and James A. Inciardi. 2007. “Use and Misuse of Buprenorphine in the Management of Opiod Addiction.” Journal of Opiod Management 3: 302-308.
Inciardi, James A. , Hilary L. Surratt, Yamilka Lugo and Theodore J. Cicero. 2007. “The Diversion of Prescription Opioid Analgesics.” Law Enforcement Executive Forum 7 (7): 27-141.